In addition, claudin-7 and claudin-7/CD81 levels in EVs showed no significant correlation with ER, PR, and HER2 status in breast cancer patients, indicating that claudin-7 might be a universal biomarker for the early diagnosis of breast cancer [164]. This evidence concerns the gene ERBB2 and breast carcinoma.